Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

Andrew Kneebone(The University of Sydney), Carol Fraser‐Browne(Auckland City Hospital), Gillian Duchesne(Peter MacCallum Cancer Centre), Richard Fisher(Peter MacCallum Cancer Centre), Mark Frydenberg(Monash University), Alan Herschtal(Peter MacCallum Cancer Centre), Scott Williams(Peter MacCallum Cancer Centre), Chris Brown(National Health and Medical Research Council), Warick Delprado(Macquarie University), Annette Haworth(The University of Sydney), David Joseph(The University of Western Australia), Jarad Martin(University of Newcastle Australia), J. H. Matthews(Auckland City Hospital), Jeremy Millar(Alfred Health), Mark Sidhom(Liverpool Hospital), Nigel Spry(Genesis HealthCare), Colin Tang(Edith Cowan University), Sandra Turner(The University of Sydney), Kirsty Wiltshire(Peter MacCallum Cancer Centre), Henry H. Woo(The University of Sydney), Ian D. Davis(Australian and New Zealand Urogenital and Prostate Cancer Trials Group), Tee Lim(Curtin University), Maria Pearse(Auckland City Hospital)
The Lancet Oncology
September 28, 2020
10.1016/s1470-2045(20)30456-3
Cited by 361Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis